LE

Leyden Labs

Leiden, NL · 7 known investors

leydenlabs.com ↗

Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses at the nasal mucosa to prevent initial infection and transmission. The company aims to provide broad protection against influenza, COVID-19, and future respiratory viruses for the general population.

Founders & leadership

KW

Koenraad WiedhaupinFounder and Chief Executive Officer

RB

Ronald BrusinFounder and Chief Growth Officer

JG

Jaap GoudsmitinFounding Scientist and Senior Advisor

Investors · 7

F-

F-Prime Capital✓ verified

PO

Polaris Partners✓ verifiedBoston · $500K – $5M

QI

Qiming Venture Partners✓ verifiedShanghai · $5M – $134M

CL

ClavystBioSingapore

CO

Connecticut InnovationsNew Haven · $500K – $2M

F-

F-Prime Capital PartnersCambridge · $3M – $10M

GV

GV (Google Ventures)Mountain View · $250K – $50M